Patents by Inventor Christian Schürch

Christian Schürch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD70 and BCR-ABL inhibitor combination therapy
    Patent number: 11571475
    Abstract: Provided are methods and compositions for the treatment of a BCR-ABL1 related disorder (e.g., chronic myelogenous leukemia) using a therapeutic combination of a WNT signaling pathway inhibitor and a BCR-ABL1 tyrosine kinase inhibitor.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: February 7, 2023
    Assignee: University of Bern
    Inventors: Carsten Riether, Christian Schürch, Adrian Ochsenbein, Karen Silence
  • Anti-CD70 combination therapy
    Patent number: 10391168
    Abstract: Provided are methods and compositions for the treatment of a BCR-ABL1 related disorder (e.g., chronic myelogenous leukemia) using a therapeutic combination of a WNT signaling pathway inhibitor and a BCR-ABL1 tyrosine kinase inhibitor.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: August 27, 2019
    Assignee: UNIVERSITY OF BERN
    Inventors: Carsten Riether, Christian Schürch, Adrian Ochsenbein, Karen Silence